Journal of Thyroid Research

Thyroid Oncology


Publishing date
15 Jul 2011
Status
Published
Submission deadline
15 Jan 2011

1Department of Endocrinology, Portuguese Cancer Institute, Lisboa, Portugal; Faculty of Medical Sciences, The New University of Lisbon, Lisboa, Portugal

2Section of Endocrinology, Hospital del Salvador, University of Chile, Santiago, Chile

3Department of Endocrinology, Fleury Medicine and Health, Cancer Institute of São Paulo (ICESP), University of São Paulo Medical School (USP), São Paulo, Brazil

4Department of Endocrine Neoplasia and Hormonal Disorders, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA


Thyroid Oncology

Description

Thyroid cancer is the unifying designation for malignancies deriving either from thyroid follicular cells (papillary, follicular, and anaplastic thyroid cancers) or from neuroendocrine “C” cells (medullary thyroid cancer). The reported incidence has been rising mainly due to the increase of papillary thyroid carcinoma. The causes of this increase are still controversial.

Thyroid cancer is mostly sporadic. However, evidence for a familial form is well documented. Whereas the susceptibility gene for hereditary medullary thyroid carcinoma is well defined, little is known about possible genes that may cause familial nonmedullary thyroid carcinoma.

Clinical outcome is extremely variable ranging from one of the most indolent to one of the most aggressive, among solid tumors. Therapeutic options for patients with progressive thyroid cancer are relatively ineffective.

Over the past two decades, the pathways involved in thyroid cancer development and progression have begun to be elucidated. Molecular-targeted therapies are currently being evaluated in clinical trials in both differentiated thyroid carcinoma and medullary thyroid carcinoma with promising preliminary results. Novel therapies are needed to improve dismal outcomes of anaplastic thyroid carcinoma.

We invite authors to submit original research and review articles on topics listed below. Papers that bridge across these areas are of special interest. Potential planned topics include, but are not limited to:

  • Risk stratification in thyroid cancer
  • Molecular markers in thyroid cancer
  • Conventional management of thyroid cancer
  • Molecular-targeted therapy in thyroid cancer
  • Familial thyroid cancer
  • Pediatric thyroid cancer

Before submission authors should carefully read over the journal's Author Guidelines, which are located at http://www.hindawi.com/journals/jtr/guidelines/. Prospective authors should submit an electronic copy of their complete manuscript through the journal Manuscript Tracking System at http://mts.hindawi.com/ according to the following timetable:


Articles

  • Special Issue
  • - Volume 2011
  • - Article ID 467570
  • - Editorial

Thyroid Oncology

Maria João M. Bugalho | Nelson Wohllk | ... | Maria E. Cabanillas
  • Special Issue
  • - Volume 2011
  • - Article ID 985780
  • - Review Article

Challenges Associated with Tyrosine Kinase Inhibitor Therapy for Metastatic Thyroid Cancer

Maria E. Cabanillas | Mimi I. Hu | ... | Naifa L. Busaidy
  • Special Issue
  • - Volume 2011
  • - Article ID 845362
  • - Review Article

Thyroid Carcinoma in Children and Adolescents—Systematic Review of the Literature

Fernanda Vaisman | Rossana Corbo | Mario Vaisman
  • Special Issue
  • - Volume 2011
  • - Article ID 102636
  • - Review Article

Targeted Treatment of Differentiated and Medullary Thyroid Cancer

Shannon R. Bales | Inder J. Chopra
  • Special Issue
  • - Volume 2011
  • - Article ID 678357
  • - Review Article

How to Treat a Signal? Current Basis for RET-Genotype-Oriented Choice of Kinase Inhibitors for the Treatment of Medullary Thyroid Cancer

Hugo Prazeres | Joana Torres | ... | Paula Soares
  • Special Issue
  • - Volume 2011
  • - Article ID 251680
  • - Research Article

Subclassification of the “Grey Zone” of Thyroid Cytology; A Retrospective Descriptive Study with Clinical, Cytological, and Histological Correlation

Mariella Bonzanini | Pierluigi Amadori | ... | Paolo Dalla Palma
  • Special Issue
  • - Volume 2011
  • - Article ID 895470
  • - Review Article

The Role of Epigenetic Alterations in Papillary Thyroid Carcinogenesis

Ogechukwu P. Eze | Lee F. Starker | Tobias Carling
  • Special Issue
  • - Volume 2011
  • - Article ID 264248
  • - Research Article

Predominant RET Germline Mutations in Exons 10, 11, and 16 in Iranian Patients with Hereditary Medullary Thyroid Carcinoma

Mehdi Hedayati | Marjan Zarif Yeganeh | ... | Fereidoun Azizi
  • Special Issue
  • - Volume 2011
  • - Article ID 815826
  • - Review Article

Medullary Thyroid Carcinoma: Molecular Signaling Pathways and Emerging Therapies

Karen Gómez | Jeena Varghese | Camilo Jiménez
  • Special Issue
  • - Volume 2011
  • - Article ID 639156
  • - Clinical Study

Differences in the Form of Presentation between Papillary Microcarcinomas and Papillary Carcinomas of Larger Size

Carles Zafon | Juan Antonio Baena | ... | Jordi Mesa
Journal of Thyroid Research
 Journal metrics
See full report
Acceptance rate-
Submission to final decision-
Acceptance to publication-
CiteScore4.500
Journal Citation Indicator0.450
Impact Factor2.1
 Submit Check your manuscript for errors before submitting

Article of the Year Award: Impactful research contributions of 2022, as selected by our Chief Editors. Discover the winning articles.